Sign in
Join
Click here - to use the wp menu builder
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
FREE STOCK ALERTS
Subscribe
Home
Featured Companies
Power Nickel
News Room
Videos
Privacy Policy
Disclaimer
type here...
Search
Facebook
Instagram
Twitter
Youtube
Wednesday, October 9, 2024
Claim Report Now: Power Nickel [TSX: PNPN] [OTC: PNPNF]
Home
Featured Companies
Power Nickel
News Room
Videos
FREE TRADING COURSE
Home
Featured Companies
Power Nickel
News Room
Videos
FREE TRADING COURSE
Uncategorized
Featured Companies
News Room
Videos
Worthington Enterprises Names Joseph Hayek Chief Executive Officer; Effective Nov. 1
Uncategorized
Investing Today
-
October 8, 2024
Joe Hayek COLUMBUS, OHIO, Oct. 08, 2024 (GLOBE NEWSWIRE)...
Toll Brothers Announces Grand Opening of Clubhouse and Amenities at Middletown Walk in Monmouth County, New Jersey
Uncategorized
Investing Today
-
October 8, 2024
New luxury townhome community offers urban-inspired living with new onsite resort-style amenitiesMIDDLETOWN, N.J., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL),...
Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Uncategorized
Investing Today
-
October 4, 2024
SOUTH SAN FRANCISCO, Calif., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage...
China has ‘unleashed’ ‘monetary fiscal bazooka’: KraneShares CIO
Uncategorized
Investing Today
-
October 3, 2024
The Hang Seng (^HSI) ended the day lower after 13 straight days of gains following a wave of stimulus...
More Adults With Type 1 Diabetes Achieved A1C Goal (<7%) After Switching From Multiple Daily Insulin Injections or Automated Pumps to Inhaled Insulin (Afrezza®)
Uncategorized
Investing Today
-
September 30, 2024
30-week results from the Phase 4 INHALE-3 study expand upon the positive 17-week data presented earlier this year at...
